Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 3 drugs
Sofosbuvir (tradename Sovaldi) is a direct acting antiviral medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the...
Approved
Matched Synonyms: … Sofosbuvir
Matched Name: … Sofosbuvir
Matched Description: … Sofosbuvir and other direct acting antivirals are therefore very potent options for the treatment of ... When combined together, ledipasvir and sofosbuvir as the combination product Harvoni has been shown to ... count, and neuropsychiatric effects [A19635]. …
Matched Mixtures name: … Sofosbuvir and Velpatasvir ... Ledipasvir and Sofosbuvir
Matched Categories: … sofosbuvir and velpatasvir ... sofosbuvir, velpatasvir and voxilaprevir ... sofosbuvir and ledipasvir ... sofosbuvir ... Nucleic Acids, Nucleotides, and Nucleosides …
Velpatasvir is a Direct-Acting Antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common...
Approved
Investigational
Matched Synonyms: … Velpatasvir
Matched Name: … Velpatasvir
Matched Description: … with sofosbuvir for all six genotypes of Hepatitis C [L852]. ... inhibitors, such as [DB09027] and [DB09102], making it a highly potent and reliable alternative for treatment ... Velpatasvir is a Direct-Acting Antiviral (DAA) medication used as part of combination therapy to treat …
Matched Mixtures name: … Sofosbuvir and Velpatasvir
Matched Categories: … sofosbuvir and velpatasvir ... sofosbuvir, velpatasvir and voxilaprevir …
Voxilaprevir is a Direct-Acting Antiviral (DAA) medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common...
Approved
Investigational
Matched Description: … and [velpatasvir] as the commercially available product Vosevi. ... Voxilaprevir has been available since July 2017 in a fixed dose combination product with [sofosbuvir] ... have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor [L935 …
Matched Categories: … sofosbuvir, velpatasvir and voxilaprevir …
Displaying all 3 drugs